BFRI

Biofrontera Inc

• NASDAQ·10/08 13:47

  Biofrontera Submits Ameluz SNDA For Expanded Actinic Keratosis Use

• TipRanks·10/08 13:37

  Biofrontera submits sNDA to FDA to expand Ameluz indication

• NASDAQ·09/18 19:27

  Biotech Stocks In Focus - IMCC +245%, XRTX +12%, SILO, BFRI

• NASDAQ·09/14 14:08

  Biofrontera Stock Drops 6% Despite Securing FDA Approval For Ameluz SNDA

• TipRanks·09/14 13:58

  Biofrontera Gains FDA Approval for Ameluz Skin Cancer Use

• TipRanks·09/14 13:35

  Biofrontera announces FDA approval of Ameluz supplemental new drug application

• TipRanks·09/10 15:55

  FDA approves label update for Biofrontera’s Ameluz Gel

• NASDAQ·09/08 04:11

  ISpecimen In Focus, Genelux Nears Phase 3 Ovarian Cancer Data, Biofrontera Awaits FDA Decision

• NASDAQ·09/08 02:28

  Biotech Stocks At 52-Week Highs - PDEX +18% On FY'26 Results, ODTX +8%, EOLS, BFRI, DRTS

• NASDAQ·08/31 09:01

  Biotech Stocks At 52-Week Highs - RNXT +12%, BLSM, RVTY, ATRC, BFRI

• NASDAQ·08/26 15:11

  Biotech Stocks Facing FDA Decision In September 2026

• TipRanks·08/24 00:23

  Biofrontera Earnings Call Highlights Growth Amid Legal Risks

• Seeking Alpha·08/13 19:13

  Biofrontera GAAP EPS of -$0.05, revenue of $12M

• NASDAQ·08/13 14:10

  Biofrontera Inc. (BFRI) Reports Q2 Loss, Beats Revenue Estimates

• Dow Jones·08/13 12:52

  *Biofrontera 2Q Net Product Rev $12.0M >BFRI